Table of Content

Executive Summary
1. Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Snapshot 2025 and 2032
2. Market Opportunity Assessment, 2025-2032, US$ Mn
3. Key Market Trends
4. Industry Developments and Key Market Events
5. Demand Side and Supply Side Analysis
6. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definitions
2. Value Chain Analysis
3. Macro-Economic Factors
  1. Global GDP Outlook
  2. Global Construction Industry Overview
  3. Global Mining Industry Overview
4. Forecast Factors – Relevance and Impact
5. COVID-19 Impact Assessment
6. PESTLE Analysis
7. Porter's Five Forces Analysis
8. Geopolitical Tensions: Market Impact
9. Regulatory and Technology Landscape
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
4. Trends
Price Trend Analysis, 2019 – 2032
1. Region-wise Price Analysis
2. Price by Segments
3. Price Impact Factors
Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Cancer Grade
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Mn) Analysis by Cancer Grade, 2019-2024
  3. Current Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
    1. Low-grade Bladder Cancer
    2. High-grade Bladder Cancer
  4. Market Attractiveness Analysis: Cancer Grade
3. Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Drug Type
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Mn) Analysis by Drug Type, 2019-2024
  3. Current Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
    1. Immunotherapy
      1. Bacillus Calmette-Guerin
      2. Avelumab
      3. Nivolumab
      4. Pembrolizumab
      5. Others
    2. Chemotherapy
      1. Mitomycin C
      2. Docetaxel
      3. Paclitaxel
      4. Cisplatin
      5. Others
    3. Targeted Therapy
      1. Erdafitinib
      2. Enfortumab Vedotin-ejfv
      3. Sacituzumab Govitecan
      4. Others
  4. Market Attractiveness Analysis: Drug Type
4. Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Distribution Channel
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
  3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Specialty Pharmacies
    4. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia & Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. U.S.
  2. Canada
4. North America Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. North America Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
Europe Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. Germany
  2. Italy
  3. France
  4. U.K.
  5. Spain
  6. Russia
  7. Rest of Europe
4. Europe Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. Europe Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
East Asia Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
4. East Asia Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. East Asia Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
South Asia & Oceania Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of SAO
4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
Latin America Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of LATAM
4. Latin America Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. Latin America Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
Middle East & Africa Non-muscle Invasive Bladder Cancer Therapeutics Industry Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
1. Key Highlights
2. Pricing Analysis
3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
  1. GCC Countries
  2. South Africa
  3. Northern Africa
  4. Rest of MEA
4. Middle East & Africa Market Size (US$ Mn) Forecast, by Cancer Grade, 2025-2032
  1. Low-grade Bladder Cancer
  2. High-grade Bladder Cancer
5. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Type, 2025-2032
  1. Immunotherapy
    1. Bacillus Calmette-Guerin
    2. Avelumab
    3. Nivolumab
    4. Pembrolizumab
    5. Others
  2. Chemotherapy
    1. Mitomycin C
    2. Docetaxel
    3. Paclitaxel
    4. Cisplatin
    5. Others
  3. Targeted Therapy
    1. Erdafitinib
    2. Enfortumab Vedotin-ejfv
    3. Sacituzumab Govitecan
    4. Others
6. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. Online Pharmacies
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping
  2. Competition Dashboard
3. Company Profiles
  1. Pfizer Inc.
    1. Company Overview
    2. Product Portfolio/Offerings
    3. Key Financials
    4. SWOT Analysis
    5. Company Strategy and Key Developments
  2. Merck KGaA
  3. Merck & Co.
  4. AstraZeneca PLC
  5. Roche Holding AG (Genentech)
  6. Astellas Pharma Inc.
  7. J&J (Janssen Biotech)
  8. Cipla Inc.
  9. Amneal Pharma
  10. Bristol Myers Squibb Co.
  11. Dr. Reddy’s Laboratories, Inc.
  12. Gilead Sciences Inc.
  13. Endo Pharma
  14. UroGen Pharma, Inc.
  15. Teva Pharmaceuticals (Actavis)
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Our Media Trust

Testimonials

“Persistence Market Research has helped us immensely in compiling a sound database. Our expectations were exceeded by their research team.”

Fortune 500 Telecom Company, USA

“The market numbers supplied by Persistence Market Research helped us successfully conclude our ongoing project and we are pleased with this purchase.”

Multinational Chemical Company, USA

“The customer service provided by Persistence Market Research was great. We got our report well in time and customized to suit our business requirements.”

Multinational Electronics Company, Japan

“The way Persistence Market Research handled the entire transaction, right from Customisation to after-sales queries, has been very impressive.”

Leading Semiconductors Company, Taiwan

“Thank you for supplying the report in time for our project to go through. Commendable customer service.”

Leading Global Healthcare Fortune 500 Company, USA

“The precise information given in Persistence Market Research’s reports has been priceless to us. We are very happy with this purchase, since the analysis in the report has been important in formulating our strategies.”

Global Consulting Firm, USA

Customisation

Tailor-made research to suit your business growth

Request Sample

Non-muscle Invasive Bladder Cancer Therapeutics Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content